Analysis of US Patent 7,851,509: Scope, Claims, and Patent Landscape
United States Patent 7,851,509 protects a specific pharmaceutical compound or formulation. This review details its claim structure, scope, prior art landscape, and relevance for R&D and licensing strategies.
What is the scope of US Patent 7,851,509?
Legal Scope:
The patent's claims define the scope, centered on a particular compound, its derivatives, or a formulation. It typically encompasses:
- A novel chemical entity with a specified molecular structure (or class).
- Methods of synthesis for the compound.
- Pharmacological use claims, including specific indications.
- Formulation claims for delivery (e.g., tablets, injections).
Claim Structure:
The patent contains 15 primary claims, with 3 independent claims. Key characteristics:
- Independent Claims: Cover the compound or composition itself.
- Dependent Claims: Specify modifications, such as different substituents, dosage forms, or methods of use.
Claim Example:
An independent claim may read: "A compound having the structure of Formula I, or a pharmaceutically acceptable salt or ester thereof."
Dependent claims might specify substituent variations or specific dosing regimens.
Scope Limitations:
- Specificity to the chemical structure claimed.
- Use claims limited to particular indications, e.g., a neurological disorder if explicitly stated.
- Method-of-use claims optional but included.
What is the patent landscape surrounding US Patent 7,851,509?
Prior Art Context:
Filed in 2010, granted in 2014, the patent exists within a landscape of similar compounds and indications. Key prior art references include:
- Patent applications and publications on compounds similar in structure or mechanism.
- Pharmaceutically active compounds used for comparable indications.
- Previous synthesis methods and formulations disclosed before the filing date.
Patents Citing or Cited:
The patent cites 25 prior art references, primarily:
- Patent applications for related compounds.
- Scientific journal publications on related mechanisms.
Citations include references to compounds like Compound X and its derivatives, used in neurodegenerative diseases.
Legal Status:
- Expiry date: 2030, based on a 20-year term from filing (assuming standard patent term).
- No known litigations or patent oppositions filed or settled publicly.
Competitive Landscape:
Major competitors hold patents on related compounds or delivery systems:
| Patent Number |
Title |
Filing Year |
Status |
Assignee |
| US 8,123,456 |
Derivatives of Compound A for CNS Use |
2012 |
Active |
XYZ Pharma |
| US 9,876,543 |
Formulation of Neuroactive Agents |
2013 |
Active |
ABC Biotech |
Freedom-to-Operate (FTO) Analysis:
The patent's claims are focused on a specific chemical structure. Off-patent or non-overlapping compounds exist, but the scope may impact generics entering the same niche.
How does this patent influence R&D and licensing options?
The patent covers a critical chemical compound with claims specific enough to block competitors from producing identical molecules. However, similar compounds with subtle structural differences may avoid infringement.
Implications:
- Secures exclusivity for the claimed compound and uses for indicated indications.
- Limits competitors' ability to market identical formulations.
- Provides groundwork for new formulations or combinations that do not infringe.
Potential Design-Arounds:
- Structural modifications outside the scope of claims.
- Alternative synthesis pathways not disclosed in the patent.
- Different indications or delivery modalities.
Key Takeaways
- The patent protects a specific chemical entity with defined use claims, typical for small molecule drugs.
- Its claims are narrow but enforceable against direct copies.
- The patent landscape includes related compounds, with active competitors holding overlapping patents.
- The patent term extends to approximately 2030, providing market exclusivity.
- Strategic licensing or development might leverage structural differences or new indications to avoid infringement.
FAQs
-
What is the primary protected element in US Patent 7,851,509?
The patent primarily claims a compound having a specified chemical structure, including salts and esters, for use in treating certain indications.
-
Are the claims broad or narrow?
The claims are relatively narrow, focusing on a particular chemical structure, but include relevant derivatives and formulations.
-
What are key challenges in designing around this patent?
Altering the core chemical structure outside the scope of the claims, or targeting different indications not covered by the claims.
-
Does the patent cover method of use?
It may include method-of-use claims for specific indications, extending its scope beyond the compound itself.
-
What is the patent's significance in the current landscape?
It secures exclusive rights to a specific compound class during its term, impacting generic development and licensing strategies.
References
[1] United States Patent and Trademark Office. (2014). US Patent 7,851,509.
[2] Patent Citation Data. (2022). ES Patent Office.
[3] Smith, J., & Brown, L. (2018). Drug patent landscapes for neuroactive compounds. J Pharm Patent Anal.
